Arabic Arabic English English French French German German
dark

Beta-glucans is a potential inhibitor of ovarian cancer: based on molecular and biological aspects.

PMID: 

Curr Pharm Biotechnol. 2021 Aug 9. Epub 2021 Aug 9. PMID: 34375183

Abstract Title: 

Beta-glucans is a potential inhibitor of ovarian cancer: based on molecular and biological aspects.

Abstract: 

Ovarian cancer is a lethal type of cancer which is initiated in the ovaries and affects 1 out of every 75 women. Due to the high number of deaths (almost 152,000) related to this cancer, it seems that novel effiecient therapeutic methods are required in this field. Beta-glucans are a type of glucose linear polymers which have proven to have a lot of advantageous activities. Recently, investigations have declared that these polysaccharides have the potential to be used as anti-cancer drugs. These agents are able to affect several mechanisms such as inflammation and apoptosis and that is how cancers are prone to be affected by them. In this review, we attempt to investigate the role of beta-glucans on ovarian cancer. We hope that this paper might give novel insights in the field of ovarian cancer treatment.

read more

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Oat β-glucan alleviates DSS-induced colitis via regulating gut microbiota metabolism in mice.

Next Post

A review of the role of medicinal mushrooms in brain cancer therapies.

Related Posts
Total
0
Share